|
MAD2L1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.824200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.876800E-01 |
| Normal-vs-Stage2 |
2.082800E-01 |
| Normal-vs-Stage3 |
3.889400E-01 |
| Normal-vs-Stage4 |
4.807600E-01 |
| Stage1-vs-Stage2 |
5.328500E-02 |
| Stage1-vs-Stage3 |
1.543160E-01 |
| Stage1-vs-Stage4 |
3.148800E-01 |
| Stage2-vs-Stage3 |
7.079900E-03 |
| Stage2-vs-Stage4 |
3.096400E-02 |
| Stage3-vs-Stage4 |
9.937800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.711800E-01 |
| Normal-vs-AfricanAmerican |
7.083200E-01 |
| Normal-vs-Asian |
7.343200E-01 |
| Caucasian-vs-AfricanAmerican |
3.582800E-01 |
| Caucasian-vs-Asian |
1.519230E-01 |
| AfricanAmerican-vs-Asian |
9.123400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.026600E-01 |
| Normal-vs-Female |
9.535600E-01 |
| Male-vs-Female |
5.754600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.402800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.390400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.095000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.489610E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.980100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.601600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.637650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.308400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.097170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.822220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.474200E-02 |
| Classical-VS-Follicular |
1.776870E-03 |
| Classical-VS-Other |
6.979200E-01 |
| Classical-VS-Normal |
6.298400E-01 |
| Tall-VS-Follicular |
1.406380E-04 |
| Tall-VS-Other |
1.720240E-01 |
| Tall-VS-Normal |
5.734000E-02 |
| Follicular-VS-Other |
5.057400E-01 |
| Follicular-VS-Normal |
1.887980E-01 |
| Other-VS-Normal |
9.257800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.187000E-01 |
| Normal-vs-N1 |
6.383000E-01 |
| N0-vs-N1 |
7.072600E-01 |
|
|
